PharmiWeb.com - Global Pharma News & Resources
04-Dec-2018

Laurence Fishburne Hosts an Upcoming "Information Matrix" Segment that Discusses Melanoma

Laurence Fishburne Hosts an Upcoming "Information Matrix" Segment that Discusses Melanoma An upcoming segment of the award-winning program discusses this cancer with specialists.

PR Newswire

WEST PALM BEACH, Fla., Dec. 4, 2018

WEST PALM BEACH, Fla., Dec. 4, 2018 /PRNewswire-PRWeb/ -- Respected actor Lawrence Fishburne hosts "Information Matrix", an educational series that covers topics that impact the modern world and appeals to sophisticated audiences everywhere. An upcoming episode discusses melanoma.

Melanoma is typically a type of skin cancer, and it begins in cells that produce the melanin pigment that provides color to the eyes, skin and hair. Melanoma often develops in moles, and having moles is a risk factor for melanoma. However, most moles don't develop melanoma.

The American Cancer Society estimates for 2017 include 87,000 new melanoma diagnoses - 52,000 in men and 35,0000 in women. About 10,000 people die of melanoma each year.

Melanoma is 20 times more common in those with white skin versus those with darker skin tones. Overall, the risk of getting melanoma is about 3 percent for those with white skin and 0.1 for those with black skin. Individual risk is influenced by a variety of factors.

The risk of melanoma increases as people get older and the average age for a melanoma diagnosis is 63. However, it's not unusual for those under 30 to develop the disease. In fact, it's especially common in young women.

Early-stage melanomas are usually treated with surgery alone, but advanced cancers may require more aggressive treatment plans, including a combination of procedures.

The segment will be informative, and the guests will help viewers understand the risk factors and treatment available to those who develop melanoma. Anyone interested in their health will not want to miss this the edition of "'Information Matrix."

 

SOURCE Information Matrix

Editor Details

Last Updated: 04-Dec-2018